0000899243-20-002212.txt : 20200128 0000899243-20-002212.hdr.sgml : 20200128 20200128160619 ACCESSION NUMBER: 0000899243-20-002212 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200126 FILED AS OF DATE: 20200128 DATE AS OF CHANGE: 20200128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DesRosier Thomas CENTRAL INDEX KEY: 0001435744 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37465 FILM NUMBER: 20554285 MAIL ADDRESS: STREET 1: 65 HAYDEN AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Seres Therapeutics, Inc. CENTRAL INDEX KEY: 0001609809 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 274326290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617 945 9626 MAIL ADDRESS: STREET 1: 200 SIDNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Seres Health, Inc. DATE OF NAME CHANGE: 20140603 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-01-26 0 0001609809 Seres Therapeutics, Inc. MCRB 0001435744 DesRosier Thomas C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET CAMBRIDGE MA 02139 0 1 0 0 Chief Legal Officer and EVP COMMON STOCK 2020-01-26 4 M 0 25000 A 41054 D RESTRICTED STOCK UNITS 2020-01-26 4 M 0 25000 0.00 D Common Stock 25000 0 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units are fully vested and do not have an expiration date. /s/ Thomas J. DesRosier 2020-01-28